Anzeige
Mehr »
Samstag, 05.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
45 Leser
Artikel bewerten:
(0)

Bangladesh Triples Linear Accelerator Capacity by Ordering Advanced Radiotherapy Equipment From Varian Medical Systems


DHAKA, Bangladesh, March 8 /PRNewswire-FirstCall/ -- Varian Medical Systems , world leader in radiotherapy equipment and products, has been selected to supply four linear accelerators to public hospitals in Bangladesh as the country's government embarks on a radical upgrade of cancer treatment capabilities.

Three of the Clinac(R) linear accelerators will be installed at the National Institute of Cancer Research Hospital (NICRH) in Dhaka and the fourth cancer treatment machine is bound for the Dhaka Medical College Hospital. Up to now, there have only been two accelerators in the whole country, one at a Ministry of Defence hospital and one at a private center, both of them more than 10 years old.

"Bangladesh is a developing country and many of our people are poor, but there is a growing awareness of modern cancer treatments and many people have had to go to neighbouring countries such as India for treatment," said Dr. Farhad Haleem, project director at the NICRH. "These modern treatment machines will enable us to deliver more effective treatments for our patients."

He said that the three new linear accelerators at the NICRH will make it possible for his hospital to begin treating cancers with modern external beam radiotherapy. Up to now, the NICRH has had to deliver radiotherapy treatments using dated cobalt machines that have limited capabilities.

"With the cobalt machines we have had to be very careful about skin reaction and we have not been able to effectively treat deep-seated tumors. Now, we will be able to treat cancers such as lung tumors and pelvic tumors while sparing surrounding healthy tissue from damage," he added.

Fritz Derrer, regional sales director with Varian Medical Systems, said, "The Bangladeshi government is striving to offer the best treatments for its cancer patients. It has acquired the most sophisticated treatment machines and systems available as it moves towards giving a country of 140 million people the cancer treatment infrastructure it requires. We are delighted to be working closely with the government on this important project."

About Varian Medical Systems

Varian Medical Systems, Inc. of Palo Alto, California is the world's leading supplier of equipment and software for treating cancer. The company is also a premier supplier of components including X-ray tubes and flat-panel detectors for medical, scientific, and industrial imaging. Varian Medical Systems employs approximately 3,280 people who are located at manufacturing sites in North America and Europe and in its 55 sales and support offices around the world. The company operates manufacturing and engineering centers in Baden (Switzerland), Crawley (England), Haan (Germany), Helsinki (Finland) and Toulouse (France) and has headquarters for Europe, Middle East, India and Africa (EMEA) based in Zug, Switzerland. Additional information is available on the company's web site at http://www.varian.com/.

Forward Looking Statements

Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "can" and "expect," constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.

Editorial contact: Neil Madle, Varian Medical Systems, +44-7786-526068
© 2006 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.